substance misuse

A drug is a chemical substance that acts on the brain and nervous system, changing a person’s mood, emotion or state of consciousness. Drugs are often classified by the effect they have.
Stimulants, such as cocaine, make people feel full of energy. Depressants (or sedatives), such as heroin, make people feel relaxed. Hallucinogens, such as LSD, make people see, feel or hear things that are not real. Drug or substance misuse is when a person regularly takes one or more drugs to change their mood, emotion or state of consciousness.

Our substance misuse Blogs

Cannabis use in college: genetic predispositions less influential than social environment

nick-harsell-7NpU3EdryP0-unsplash

Sally Turner reviews a recent study exploring cannabis use in college, which provides useful evidence relating to how universities could promote a sense of community, belonging and support to students who use cannabis.

[read the full story...]

#SmokingAndMentalHealth conversations: NIHR 3 schools webinar

Tom 01 Smoking and Mental Health cover

SmokingAndMentalHealth – Carolyn Chew-Graham summarises the conversations that took place at the Smoking and Mental Health webinar on 28th September 2022.

[read the full story...]

E-cigarettes vs nicotine patches: are either adequate to support pregnant smokers?

ruvim-noga-pazM9TQJ2Ck-unsplash

In her debut blog, Tuba Saygın Avşar summarises a recent RCT, which finds that “E-cigarettes might help women who are pregnant to stop smoking, and their safety for use in pregnancy is similar to that of nicotine patches.”

[read the full story...]

Schizophrenia and cannabis use: new evidence measures risk of relapse

Over 20% of cannabis users experience a psychotic relapse within 24 months of treatment.

In her debut blog, Sally Turner considers a recent study on cannabis use and clinical outcomes in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.

[read the full story...]

Substance use is higher and more excessive in transgender people: evidence, limitations and gaps

jorge-saavedra-jbxL_EXEZB8-unsplash

Ivan Ezquerra-Romano summarises a systematic review looking into the prevalence of substance use among transgender people compared to their cisgender counterparts.

Today we also announce the launch of a new survey that will help us understand alcohol use in UK transgender and non-binary people.

[read the full story...]

The North American Opioid Crisis: how it came about and how to manage it

Close,Up,Of,Young,Woman,Taking,Prescription,Pill.,Medicine,,Health

Rob Poole explores the recently published Stanford-Lancet Commission report on the North American Opioid Crisis, which aims to understand the opioid crisis, propose solutions to the crisis in the USA and Canada, and attempt to stop its spread internationally.

[read the full story...]

How to measure cannabis use: introducing the ‘International Cannabis Toolkit’ or iCannToolkit

Marijuana,And,Weight,Loss.,Two,Green,Leaf,Of,Marijuana,,Hemp

Ian Hamilton looks at the new International Cannabis Toolkit (iCannToolkit) and considers why it’s so important that we have an internationally agreed and standardised measure for cannabis use.

[read the full story...]

Can psychosocial interventions help reduce parental substance use?

Little,Boy,Is,Playing,A,Toy,Car,And,Looking,Sadly

In her debut blog, Lilli Waples summarises a recent Cochrane Review on the effectiveness of psychosocial interventions to reduce parental substance use.

[read the full story...]

Opioid Agonist Treatment associated with 50% lower risk of mortality, but political epiphany still needed to reduce drug-related deaths

person being helped from pill bottle by healthcare provider - addiction recovery concept

Ian Hamilton appraises a systematic review and meta-analysis on the association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence.

[read the full story...]